Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 319

    1.

    Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.

    van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM; DALI Study Group.

    Diabetes Care. 2003 Apr;26(4):1216-23.PMID: 12663600 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.

    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.

    Am Heart J. 2003 Dec;146(6):1007-14.PMID: 14660992 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.

    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.

    Diabetes. 1997 Dec;46(12):2082-7.PMID: 9392500 [PubMed - indexed for MEDLINE]Related articles

    4.

    Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.

    Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.

    Arterioscler Thromb Vasc Biol. 2000 May;20(5):1323-9.PMID: 10807749 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

    Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.

    Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54.PMID: 12117730 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.

    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.

    Biomed Pharmacother. 2004 Dec;58(10):619-27.PMID: 15589073 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of HMG-CoA reductase inhibitor on plasma cholesteryl ester transfer protein activity in primary hypercholesterolemia: comparison among CETP/TaqIB genotype subgroups.

    Kotake H, Sekikawa A, Tokita Y, Ishigaki Y, Oikawa S.

    J Atheroscler Thromb. 2002;9(5):207-12.PMID: 12409629 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.

    Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.

    Nephron. 2000 Apr;84(4):333-41.PMID: 10754410 [PubMed - indexed for MEDLINE]Related articles

    9.

    Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.

    van Hoek M, van Tol A, van Vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM.

    Curr Med Res Opin. 2009 Jan;25(1):93-101.PMID: 19210142 [PubMed - indexed for MEDLINE]Related articles

    10.

    A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.

    Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets JB, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J.

    Atherosclerosis. 2002 Apr;161(2):269-79.PMID: 11888509 [PubMed - indexed for MEDLINE]Related articles

    12.

    The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

    Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ.

    N Engl J Med. 1998 Jan 8;338(2):86-93.PMID: 9420339 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.

    Guerin M, Lassel TS, Le Goff W, Farnier M, Chapman MJ.

    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):189-97.PMID: 10634817 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

    Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.

    Atherosclerosis. 2002 Apr;161(2):469-74. Erratum in: Atherosclerosis. 2003 Feb;166(2):415.. Liu Simm [corrected to Liu Simin]. PMID: 11888533 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group.

    J Clin Endocrinol Metab. 2005 Jul;90(7):4198-204. Epub 2005 Apr 19.PMID: 15840744 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.

    Cuchel M, Wolfe ML, deLemos AS, Rader DJ.

    Atherosclerosis. 2002 Jul;163(1):169-74.PMID: 12048136 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).

    Klerkx AH, de Grooth GJ, Zwinderman AH, Jukema JW, Kuivenhoven JA, Kastelein JJ.

    Eur J Clin Invest. 2004 Jan;34(1):21-8.PMID: 14984434 [PubMed - indexed for MEDLINE]Related articles

    18.

    TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.

    Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, Smelt AH.

    Eur J Hum Genet. 2005 Jul;13(7):877-82.PMID: 15856070 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.

    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.

    Circulation. 2005 Jan 25;111(3):278-87. Epub 2005 Jan 17.PMID: 15655129 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.

    Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ.

    Atherosclerosis. 1994 Sep 30;110(1):35-44.PMID: 7857368 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data